… drugmaker beat estimates for revenue and profit for the third quarter … ended December. Ebitda stands for earnings … said at a post-earnings media briefing. The … quarter,” Amey Chalke, pharma research analyst, JM Financial …

… Limited (NYSE:RDY) Q3 2025 Earnings Call Transcript January 23, 2025 … payout. As a result, profit before-tax for the quarter … have replaced five global among pharma companies assessed in the 2024 … rough quarterly estimate smoothly till 3Q of next year and …

… drugmakers by sales, reported a bigger-than-expected third-quarter profit … 39;s consolidated net profit increased nearly 49% to … -earnings call. Over the past two days, India pharma … headache for Indian generic drugmakers already struggling with slowing …

… reported fourth-quarter core earnings above market expectations … prevent contamination in pharmaceutical and medical device production … Getinge bought in the third quarter, also posted " … sales. Its adjusted operating earnings before amortisation (EBITA) …

… ’s largest drugmaker by sales, reported a bigger-than-expected third-quarter profit on … . The company’s consolidated net profit increased nearly 49% to 15 …

… third quarter ended December 28, 2024 (the “third quarter … includes pharmaceutical, …                                   Gross Profit     19,679       20,936       63 …   9,243                                             Diluted Earnings Per Share     0.48       0 …

… third quarter results for financial year 2024-25, the Q3 earnings … Motilal Oswal Financial Services, Piramal Pharma, Novartis India, Modi Naturals … Q3 results Infosys Q3 earnings on January 16:  … Updates: Check Q3 Results, Earnings for Hindustan Zinc, Hyundai …

… and Divya Pharmacy Q3 Results Today Highlights: Check Q3 Results, Earnings for … on Monday released its fiscal third quarter earnings with profit at Rs 2147.35 … quarters. We have delivered record profits during the quarter, with EBTIDA …

The third quarter (Q3 FY25) earnings season is … Oswal Financial Services, Piramal Pharma, Rites, Route Mobile, … Special Economic Zone, Ajanta Pharma, Astral, Bajaj Finserv, … Fincorp, Relaxo Footwears, Sun Pharmaceutical Industries, and Triveni Turbine. …

DUBLIN, IRELAND , Jan. 22, 2025 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that it will host a conference call to discuss its fiscal 2025 third quarter financial results at 9:00 a.m. ET on February 6, 2025. The …